B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SF3B3

MOLECULAR TARGET

splicing factor 3b subunit 3

UniProt: Q15393NCBI Gene: 234505 compounds

SF3B3 (splicing factor 3b subunit 3) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SF3B3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1trichostatin5.45232
2tacrolimus anhydrous4.4585
3molibresib3.8144
4lactacystin2.8917
5trichostatic acid [Supplementary Concept] related to trichostatin1.102

About SF3B3 as a Drug Target

SF3B3 (splicing factor 3b subunit 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented SF3B3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SF3B3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.